pubmed-article:15307912 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15307912 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
pubmed-article:15307912 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15307912 | lifeskim:mentions | umls-concept:C0009452 | lld:lifeskim |
pubmed-article:15307912 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
pubmed-article:15307912 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
pubmed-article:15307912 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
pubmed-article:15307912 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:15307912 | pubmed:dateCreated | 2004-8-13 | lld:pubmed |
pubmed-article:15307912 | pubmed:abstractText | Liver toxicity is a common side effect of antiretroviral therapy, particularly in subjects coinfected with the hepatitis C virus (HCV). The incidence of severe liver toxicity after initiation of treatment with lopinavir (LPV) as well as its possible association with LPV plasma levels were assessed in 120 HIV-infected patients (52% coinfected by HCV). The incidence of severe liver toxicity at 3 months was 1.7% and the cumulative incidence at 12 months was 4%. The development of severe liver toxicity was associated with HCV coinfection but not with LPV plasma levels. | lld:pubmed |
pubmed-article:15307912 | pubmed:language | eng | lld:pubmed |
pubmed-article:15307912 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15307912 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15307912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15307912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15307912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15307912 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15307912 | pubmed:month | Jul | lld:pubmed |
pubmed-article:15307912 | pubmed:issn | 0889-2229 | lld:pubmed |
pubmed-article:15307912 | pubmed:author | pubmed-author:SorianoVincen... | lld:pubmed |
pubmed-article:15307912 | pubmed:author | pubmed-author:González-Laho... | lld:pubmed |
pubmed-article:15307912 | pubmed:author | pubmed-author:NúñezMarinaM | lld:pubmed |
pubmed-article:15307912 | pubmed:author | pubmed-author:González-Requ... | lld:pubmed |
pubmed-article:15307912 | pubmed:author | pubmed-author:Jiménez-Nache... | lld:pubmed |
pubmed-article:15307912 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15307912 | pubmed:volume | 20 | lld:pubmed |
pubmed-article:15307912 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15307912 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15307912 | pubmed:pagination | 698-700 | lld:pubmed |
pubmed-article:15307912 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:meshHeading | pubmed-meshheading:15307912... | lld:pubmed |
pubmed-article:15307912 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15307912 | pubmed:articleTitle | Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfection. | lld:pubmed |
pubmed-article:15307912 | pubmed:affiliation | Service of Infectious Diseases and Pharmacy Unit, Hospital Carlos III, 28035 Madrid, Spain. | lld:pubmed |
pubmed-article:15307912 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15307912 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15307912 | lld:pubmed |